Bevacizumab in first-line treatment of metastatic breast cancer: a viewpoint by Xavier Pivot.

Xavier Pivot

Journal articles

Bevacizumab in first-line treatment of metastatic breast cancer: a viewpoint by Xavier Pivot.

Xavier Pivot ^{1, 2}

1 Service d'oncologie Médicale

2 RIGHT - Interactions hôte-greffon-tumeur, ingénierie cellulaire et génique - UFC (UMR INSERM 1098)

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Immunology

Complete list of metadatas

https://www.hal.inserm.fr/inserm-00479713
Contributor : Philippe Saas <>
Submitted on : Sunday, May 2, 2010 - 12:48:24 PM
Last modification on : Thursday, January 21, 2021 - 2:10:03 PM

Bevacizumab in first-line treatment of metastatic breast cancer: a viewpoint by Xavier Pivot.

Identifiers

Collections

Citation

Export

Metrics

77

Bevacizumab in first-line treatment of metastatic breast cancer: a viewpoint by Xavier Pivot.

Identifiers

Collections

Citation

Export

Share

Metrics

77